SPACs in Healthcare & Life Sciences
Download a PDF of this articleSPACs, or special purpose acquisition companies were all the rage in 2020, with the excitement not slowing down during the first quarter of 2021. For private companies looking to go public without pursuing the traditional IPO process, this alternative route to the public markets is more efficient by not requiring a roadshow or book building process, and is less influenced by broader market conditions.1 Although the current market environment is not as frothy compared to peak activity and the enthusiastic frenzy witnessed earlier in the year, intrigue remains high given the expectation of a robust year for the U.S. economy because of the COVID-19 vaccine rollout.
